The Endocrine Society lauds Novo Nordisk’s recent announcement that it would limit price increases for its therapies, including insulin, and hopes that other entities in the insulin supply chain including manufacturers, pharmacy benefit managers, and insurers will also demonstrate similar restraint to address this important issue. People with type 1 diabetes are unable to produce...
The Society and members of the Obesity Care Action Network conducted educational briefings at both the Republican and Democratic Conventions to educate policymakers about obesity, change mindsets, and increase support for access to evidence-based obesity care. Through these efforts, the goal is to make more members of Congress aware of and support the Treat and...
Hypoglycemia continues to be a critical barrier for patients with diabetes to reach their goals. Hypoglycemic unawareness or fear of low blood sugar may lead these individuals to take less insulin than prescribed or for physicians to utilize oral medications that do not contribute to these events. In an effort to understand these issues, the...
As the Centers for Medicare and Medicaid Services (CMS) begins the process to transition physician payment from a system that pays by volume to one that pays for value, the Endocrine Society continues to have concern that new payment models properly value cognitive services and not only focus on procedures. As a result, the Endocrine...
The Republican-led Congress and Democratic White House just closed out a surprisingly productive year in 2015, marked by the long-fought repeal of the Medicare physician payment system and passage of a $1.15 trillion spending bill that included a $2-billion increase for the National Institutes of Health (NIH) – two of the Endocrine Society’s top legislative...
On November 4, in conjunction with Diabetes Awareness Month, the Society held a Congressional briefing to highlight what policymakers can do to improve diabetes care in the U.S. The briefing featured Ann Albright, PhD, RD, director of the Division of Diabetes Translation at the Centers for Disease Control and Prevention (CDC), who detailed the scope...
The Endocrine Society is hosting a Congressional briefing on November 4 to examine policies to help the 29 million Americans who have diabetes and the 86 million who are likely to develop the disease. A diabetes diagnosis affects an individual’s overall health and quality of life, and the condition is costly to treat. The nation’s...
With nearly 30 million Americans living with diabetes and 86 million more at risk of developing diabetes, you might expect diabetes to be a top priority for Congress. But it’s not. That’s why members of Congress need to hear from us. In fact, it’s been five years since the last congressional hearing on diabetes and...
The Republican-led Congress and Democratic White House just closed out a surprisingly productive year in 2015, marked by the long-fought repeal of the Medicare physician payment system and passage of a $1.15 trillion spending bill that included a $2-billion increase for the National Institutes of Health (NIH) – two of the Endocrine Society’s top legislative...
